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BaCkground
Commercial gestational surrogacy (CGS) is 
unique among assisted reproductive services 
in its ability to attract disapprobation. Allied 
practices such as in vitro fertilisation (IVF), 
oocyte and sperm donation also enable infer-
tile couples to reproduce through assistive 
technological and third-party interventions, 
yet they rarely attract sustained condemna-
tion. Censure arises from concerns that CGS 
involves the routine exploitation of vulner-
able, impoverished women of colour who are 
commissioned by wealthy white Westerners 
to perform a labour they would otherwise 
decline. Rationales for undertaking CGS 
are, however, multiple and complex.1 CGS is, 
moreover, increasingly used by citizens of the 
global south (often relatively impoverished 
ones) to address forms of structural infertility 
brought about by diseases such as genital 
tuberculosis.2 This intra-South demand, 
combined with the displacement of the 
fertility industry to emergent southern econ-
omies such as Thailand, Mexico and India, 
should serve to make the regulation of CGS 
a key concern for global reproductive health.
The legalisation of CGS in India in 20023 led 
to increased demand from individuals, such 
as women with serious reproductive abnor-
malities and small numbers of male homo-
sexual couples who are unable to biologically 
gestate their own children, and the market 
grew consequentially. However, in 2015 the 
Indian state, stung by critiques that CGS 
was inherently imperialist and oppressive, 
elected to ban all foreigners from accessing 
these services.4 Responding to further adverse 
publicity surrounding high-profile interna-
tional cases of abandonment of surrogate chil-
dren,5 a Surrogacy (Regulation) Bill was abruptly 
introduced in August 2016 that banned CGS 
altogether.6 Believing the key problem to lie 
in the ‘commercial’ element of the process, 
the Indian state determined to make surro-
gacy permissible only if performed altru-
istically. This, according to the Bill, would 
‘prohibit the potential exploitation of surro-
gate mothers.’7 The problem, it would seem, 
was solved … or is it?
Allowing legislation to gestate out of an 
environment of moral panic driven by prom-
inent cases, irrespective of their typicality 
or evidential basis, can result in changes 
that simply substitute one set of wrongs for 
another. Such, we argue, has been the case 
with this new regulation. In attempting to 
shut down what it perceives to be a degrading 
industry, the Bill dictates that only Indian 
women aged 25–35 years, with at least one 
existing child, and who are closely related to 
the intending couple are eligible to perform 
a surrogacy altruistically on their behalf. Any 
payment, reward or monetary incentive to the 
surrogate, her dependents or representatives 
is expressly forbidden; she may only receive 
medical expenses and insurance costs. Crim-
inal penalties of ‘not less than three years and 
fines which may extend to five lakh rupees 
[half a million USD]’ for the doctor/clinic8 
indicate the severity of the punishments for 
contravention.
ETHiCal inConsisTEnCiEs and 
ConTradiCTions
The basic presumption of the Bill, that 
banning commercial surrogacy will neces-
sarily erase its exploitative potential is, we 
argue, highly problematic as it dismisses the 
possibility that altruistic arrangements can be 
equally as exploitative as commercial ones, 
although in different ways. The legal require-
ments for becoming an altruistic surrogate 
are now so prescriptive that they prove highly 
discriminatory for couples who would fail 
to access such a ‘close relative’.i As a Delhi-
based Assisted Reproductive Technologies 
(ART) specialist, offering surrogacy services 
explained:ii ‘They [ie, the Bill] are saying you 
i A further shortcoming of the Bill is that it offers no defi-
nition of who constitutes ‘a close relative’.
ii Our Wellcome Trust funded qualitative research was 
 o
n
 22 O
ctober 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000986 on 8 October 2018. Downloaded from 
2 Parry B, Ghoshal R. BMJ Glob Health 2018;3:e000986. doi:10.1136/bmjgh-2018-000986
BMJ Global Health
have to get a close relative; such as a sister. Now, say I do 
not have any sister. I have nobody [who fits the require-
ments]; then I can’t have a child.’ As she went on to 
argue: ‘If you feel that surrogacy is going to damage a 
woman, why are you then allowing the poor relative [to 
become a surrogate]?’
We agree that the State’s position here is ethically incon-
sistent. Reports occasionally emerge of instances in which 
a sister or even a mother becomes a surrogate (for her 
own grandchild), but these are relatively rare. As Muker-
jee’s9 research reveals, very few women in India would 
voluntarily undertake surrogacy for someone within the 
family. It is imaginable therefore that such relatives, if 
found, could come under intense familial pressure to 
take up the role – especially if, for example, they are the 
daughters-in-law. We argue, therefore, that it is a gross 
error of judgement to assume that exploitation is essen-
tially an economic problem, or that familial relations are 
devoid of exploitative or coercive potentials.
Prior regulations (viz, the ART (Regulation) Bill, 2010) 
advocated surrogate anonymity (her name does not 
appear on the birth certificate) and discouraged breast 
feeding to reduce postpartum bonding and promote 
separation after birth.10 The Surrogacy (Regulation) Bill, 
2016, however, inexplicably abandons these arguments, 
allowing the commissioning parents to bring up a child 
born out of surrogacy in close proximity to the surrogate. 
We can only speculate on what toll this might take on 
the emotional health of the surrogate, the social mother 
and the child, but it seems reasonable to suggest that 
considerable psychological maladjustment could result, 
particularly if the true relationship between the surrogate 
and child is deliberately obscured or disavowed. Should 
a close relative agree (or be coerced) to become the 
surrogate but later change her mind, it would presum-
ably also prove extremely difficult for her to terminate 
the pregnancy (for whatever reason, and especially when 
not medically indicated) without permanently damaging 
familial relations. These dynamics, we suggest, are 
arguably more socially and psychologically exploitative 
of vulnerable participants than those found in trans-
parent contractual commercial relationships between 
consenting parties.
Few States legislate against payment for expended 
labour, but in this case the government is advocating 
that the surrogate receives no income for undertaking 
the pregnancy even if she left paid employment to do 
so – which we find highly discriminatory. The statement 
contained in the Bill that any women found undertaking 
a compensated surrogacy will be presumed to have been 
designed to understand, using in-depth interviews and non-participant 
observation, how and in what ways cultural expectations, conventional 
practices and beliefs shape motivations to access ART services in India. 
By mapping the spread of ART from urban to non-urban markets in 
India we have also charted the political economy of this market and the 
ethical issues this expansion invokes. These are discussed at length in 
forthcoming research papers. We are indebted to all those who stake-
holders we interviewed for this reasearch (over 120).
compelled to do so by ‘her husband, the intending couple 
or any other relative’11 fails to account for the woman’s 
own agency. As the aforementioned doctor notes: ‘Have 
you gone and checked what they [the poor women who 
are engaged in small-scale informal sector industries, 
and who often volunteer as commercial surrogates] are 
actually doing? Working in a windowless room, go and 
see how many hours you will survive there where they are 
working daily. The factories are windowless, and they are 
making all kinds of stuff … their children are loitering 
around for 10, 12, 14 hours. You think she would not 
prefer surrogacy to that?’ The presumptions made by the 
Bill are certainly highly patriarchal, as they imply that 
adult, mentally stable, although economically disadvan-
taged women lack the autonomy and decision-making 
capacity to voluntarily elect to undertake CGS as a viable 
alternative form of paid employment.
ConClusion
In August 2017, the 102nd Indian Parliamentary 
Standing Committee12 critically engaged with the Bill 
and the Committee’s critique aligns with the assessments 
we offer here. Our joint analyses suggest that this legisla-
tion still requires significant further refinement. The role 
of legislation must be to assure high standards of care, 
consent and compensation for all involved in the delivery 
of reproductive services in India. This includes prospec-
tive surrogates and commissioning couples suffering 
the ignominy of infertility that arises from intractable 
reproductive disease. Some conditions such as uterine 
abnormality or absence, for which surrogacy is the only 
remedy, are immediately evident on medical examina-
tion. The Bill’s recommended minimum 5-year waiting 
period before accessing surrogacy thus has no scientific 
basis and is both arbitrary and discriminatory.
Indian (or other) citizens who are unable to bear 
biologically related children should have the same right to 
access commercial surrogacy as another form of assisted 
reproductive service, as do those whose infertility can be 
addressed via commercial IVF or compensated gamete 
provision. Surrogacy is but one of a suite of assisted 
reproductive services all of which require a consistent 
legislative approach. Economic disadvantage can compel 
poor women to engage in surrogacy as a form of employ-
ment, however this employment need not be inherently 
exploitative. The current absence of regulatory oversight 
and lack of legal protections for commercial surrogates 
is the root cause of exploitation. We conclude there-
fore, that there is no sensible rationale for sectioning 
the regulation of surrogacy out of the pre-existing ART 
(Regulation) Bill that has been languishing without legal 
ratification for many years now. The re-embedding of 
sensibly designed regulations within a revised ART Bill 
could enable a small number of accredited clinics to offer 
compensated surrogacy services under the strict oversight 
and regulation of a body akin to the UK’s Human Fertil-
isation and Embryology Authority. This could provide 
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what all stakeholders most desire and need: a legislative 
solution that is nuanced, robust and, most importantly, 
non-discriminatory.
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